Imatinib remains the best frontline therapy in patients with chronic myeloid leukemia: Critical analysis of the <scp>ASC4FIRST</scp> trial

Authors: Nethra Srinivasan, Timothée Olivier, Alyson Haslam, Vinay Prasad

Published: 2024-09-28

DOI: HTTPS://DOI.ORG/10.1002/ajh.27477

Keywords: No keywords found.

Abstract:
No abstract found.

Source: